Evobrutinib Fails to Improve Relapse or Disability in Relapsing Multiple Sclerosis
A systematic review and meta-analysis indicates that evobrutinib does not significantly reduce relapse rates or disability progression in relapsing multiple ...
A systematic review and meta-analysis indicates that evobrutinib does not significantly reduce relapse rates or disability progression in relapsing multiple ...
A retrospective cohort study reveals that lesion-related white matter tract disconnection strongly correlates with clinical disability in relapsing-remitting multiple sclerosis ...
A cross-sectional study of 107 participants finds that adjusted empathy scores are lower in relapsing-remitting multiple sclerosis than in neuromyelitis ...
A graph theory and machine learning analysis of task-based fMRI distinguished multiple sclerosis patients from healthy controls with 95.5 percent ...
A Danish nationwide registry study found lower short-term relapse rates and few confirmed disability-worsening events among people with relapsing–remitting multiple ...
A longitudinal study of early relapsing–remitting multiple sclerosis finds that paramagnetic rim lesions and enlarged choroid plexus volume at diagnosis ...
A large Italian registry study finds no significant differences among four first-line multiple sclerosis therapies in protecting against relapse-independent disability ...
Advanced susceptibility separation imaging reveals iron loss and myelin-related changes in the brain's U-fibers of multiple sclerosis patients that track ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine